









|
| �@ŠÖ“Œ˜A�‡ŽY‰È•w�l‰ÈŠw‰ï‰ïŽ� ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ�[ƒiƒ‹ |
<< Šw‰ïŽ�‚Ö–ß‚é
<< ‘O‚̃y�[ƒW‚Ö–ß‚é
‘æ89‰ñŠw�p�W‰ï�i•½�¬7”N6ŒŽ11“ú�j
�yˆê”ʉ‰‘è�z
•w�l‰È�i1�j Žq‹{èò•”Œ´”‚ÌEndocrine carcinoma‚Ì1�Ç—á
•�ˆä�@–ƒ‹I, ‰Æ‰i�@‘�, ˆé�è�@‘¾ˆê, ŽáŒŽ�@‰ë”ü, •�“à�@–±, ˆÉ“Œ�@��ŒbŽq, “c’†�@�ƒ–ç, “c’†�@�², �²�X–Ø�@–Î
“ú–{ˆã‰È‘åŠw•�‘®‘½–€‰iŽR•a‰@ŽY•w�l‰È
“ú–{ŽY‰È•w�l‰ÈŠw‰ïŠÖ“Œ˜A�‡’n•û•”‰ï‰ï•ñ, 32(2)
232-232, 1995
|